𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Formation of liquation structure in glazes for bone china

✍ Scribed by Yu. G. Shteinberg; É. Yu. Tyurn; V. A. Berezovskaya; G. I. Kovalev


Publisher
Springer US
Year
1981
Tongue
English
Weight
419 KB
Volume
38
Category
Article
ISSN
0361-7610

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Two doses of sclerostin antibody in cyno
✍ Michael S Ominsky; Fay Vlasseros; Jacquelin Jolette; Susan Y Smith; Brian Stouch 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 691 KB

## Abstract The development of bone‐rebuilding anabolic agents for treating bone‐related conditions has been a long‐standing goal. Genetic studies in humans and mice have shown that the secreted protein sclerostin is a key negative regulator of bone formation. More recently, administration of scler

Bioinspired structure of bioceramics for
✍ Faming Zhang; Jiang Chang; Jianxi Lu; Kaili Lin; Congqin Ning 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 1024 KB

The major problem with the use of porous bioceramics as bone regeneration grafts is their weak mechanical strength, which has not been overcome to date. Here we described a novel way to solve this problem. Beta-tricalcium phosphate (beta-TCP) bioceramics with a bioinspired structure were designed an

Comparison of structure extraction metho
✍ A Laib; P Rüegsegger 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 845 KB

In vivo trabecular bone structure measurements have become available recently using high resolution quantitative computed tomography (3D-QCT) or magnetic resonance imaging. In this work different structure extraction and morphometric evaluation techniques are compared, which are of potential use for

Inhibition of sclerostin by monoclonal a
✍ Xiaodong Li; Kelly S Warmington; Qing-Tian Niu; Franklin J Asuncion; Mauricio Ba 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 779 KB

## Abstract The purpose of this study was to evaluate the effects of sclerostin inhibition by treatment with a sclerostin antibody (Scl‐AbII) on bone formation, bone mass, and bone strength in an aged, gonad‐intact male rat model. Sixteen‐month‐old male Sprague‐Dawley rats were injected subcutaneou